Harvard Management Company’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-107,252
| Closed | -$1.24M | – | 38 |
|
|
2023
Q1 | $1.24M | Hold |
107,252
| – | – | 0.13% | 38 |
|
|
2022
Q4 | $1.24M | Hold |
107,252
| – | – | 0.15% | 39 |
|
|
2022
Q3 | $1.36M | Hold |
107,252
| – | – | 0.17% | 39 |
|
|
2022
Q2 | $737K | Hold |
107,252
| – | – | 0.09% | 42 |
|
|
2022
Q1 | $1.03M | Hold |
107,252
| – | – | 0.1% | 40 |
|
|
2021
Q4 | $1.28M | Hold |
107,252
| – | – | 0.12% | 42 |
|
|
2021
Q3 | $1.74M | Hold |
107,252
| – | – | 0.1% | 36 |
|
|
2021
Q2 | $2.26M | Hold |
107,252
| – | – | 0.13% | 35 |
|
|
2021
Q1 | $1.67M | Hold |
107,252
| – | – | 0.09% | 37 |
|
|
2020
Q4 | $2.25M | Hold |
107,252
| – | – | 0.12% | 27 |
|
|
2020
Q3 | $2.17M | Buy |
+107,252
| New | +$2.17M | 0.12% | 24 |
|